Authors: Bissett, D McLeod, HL Sheedy, B Collier, M Pithavala, Y Paradiso, L Pitsiladis, M Cassidy, J

Citation: D. Bissett et al., Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034, BR J CANC, 84(3), 2001, pp. 308-312

Authors: McLeod, HL Cassidy, J Powrie, RH Priest, DG Zorbas, MA Synold, TW Shibata, S Spicer, D Bissett, D Pithavala, YK Collier, MA Paradiso, LJ Roberts, JD

Citation: Hl. Mcleod et al., Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034, CLIN CANC R, 6(7), 2000, pp. 2677-2684

Authors: Bissett, D Ahmed, F McLeod, H Cassidy, J

Citation: D. Bissett et al., Oral fluoropyrimidines in the treatment of colorectal cancer, CL ONCOL-UK, 12(4), 2000, pp. 240-245

Authors: Cheesewright, R Clark, C Bissett, D

Citation: R. Cheesewright et al., Understanding the experimental response of Coriolis massflow meters to flow pulsations, FLOW MEAS I, 10(4), 1999, pp. 207-215

Authors: Mackay, HJ Bissett, D Twelves, C Vasey, PA

Citation: Hj. Mackay et al., A pilot study of continuous infusional 5-fluorouracil, doxorubicin and cyclophosphamide in breast cancer, CL ONCOL-UK, 11(3), 1999, pp. 174-178